|
|
Substance Name: Aniracetam [USAN:INN:JAN]
RN: 72432-10-1
UNII: 5L16LKN964
InChIKey: ZXNRTKGTQJPIJK-UHFFFAOYSA-N
Note
- Mental performance enhancer.
Molecular Formula
- C12-H13-N-O3
Molecular Weight
- 219.2387
Classification Codes
- Antidepressive Agents
- Central Nervous System Agents
- Drug / Therapeutic Agent
- Mental Performance Enhancer
- Nootropic Agents
- Psychotropic Drugs
- Reproductive Effect
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Aniracetam
- Aniracetam [USAN:INN:JAN]
Synonyms
- 1-(4-Methoxybenzoyl)-2-pyrrolidinone
- 1-(p-Methoxybenzoyl)-2-pyrrolidinon
- 1-(p-Methoxybenzoyl)-2-pyrrolidinon [German]
- 1-p-Anisoyl-2-pyrrolidinone
- Aniracetam
- Aniracetamun
- Aniracetamun [INN-Latin]
- BRN 4807205
- Draganon
- NSC 758223
- Ro 13-5057
- Ro 135057
- Sarpul
- UNII-5L16LKN964
Systematic Name
- 2-Pyrrolidinone, 1-(4-methoxybenzoyl)-
Registry Numbers
CAS Registry Number
- 72432-10-1
FDA UNII
- 5L16LKN964
System Generated Number
- 0072432101
Structure Descriptors
InChI
InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3InChIKey
ZXNRTKGTQJPIJK-UHFFFAOYSA-NSmiles
COc1ccc(cc1)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 1180mg/kg (1180mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
mouse | LD50 | intravenous | > 100mg/kg (100mg/kg) | Medicamentos de Actualidad. Vol. 30, Pg. 9, 1994. | |
mouse | LD50 | oral | 3648mg/kg (3648mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
mouse | LD50 | subcutaneous | > 5gm/kg (5000mg/kg) | Drugs in Japan Vol. -, Pg. 45, 1995. | |
rabbit | LD50 | oral | > 2gm/kg (2000mg/kg) | Medicamentos de Actualidad. Vol. 30, Pg. 9, 1994. | |
rat | LD50 | intraperitoneal | 1255mg/kg (1255mg/kg) | Medicamentos de Actualidad. Vol. 30, Pg. 9, 1994. | |
rat | LD50 | intravenous | > 50mg/kg (50mg/kg) | Medicamentos de Actualidad. Vol. 30, Pg. 9, 1994. | |
rat | LD50 | oral | 4500mg/kg (4500mg/kg) | Psychopharmacology Vol. 78, Pg. 104, 1982. | |
rat | LD50 | subcutaneous | > 5gm/kg (5000mg/kg) | Drugs in Japan Vol. -, Pg. 45, 1995. |